Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk-Reference-Cited by-同舟云学术

Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

Published:2011-04 Issue:4 Volume:13 Page:349-355
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Levy Douglas E.,Byfield Stacey D.,Comstock Catherine B.,Garber Judy E.,Syngal Sapna,Crown William H.,Shields Alexandra E.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Reference45 articles.

1. National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian V. 1. 2009 2009; Available at: http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf. Accessed September 28, 2009.

2. Myriad Genetics. Myriad Genetics awarded three U.S. patents and eight international patents 2001 news release Available at: http://www.myriad.com/news/release/210288. Accessed May 14, 2008.

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considering screening for hereditary cancer syndromes at the time of obstetrical prenatal carrier screening;Cancer;2024-07-22

2. Value and demand for genetic information and ambiguity aversion revisited;Risk Management and Insurance Review;2024-05-22

3. Cascade genetic testing: an underutilized pathway to equitable cancer care?;Familial Cancer;2024-05-15

4. Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs;Familial Cancer;2024-03-26

5. Disparities in genetic testing for breast cancer among black and Hispanic women in the United States;Clinical Imaging;2024-03